Using daily voice recordings to estimate risk of worsening in heart failure
Tests a voice-based software tool in adults living with chronic heart failure.
Key facts
- Who runs it
- Noah Labs
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Voice-based Outcome Identification and Clinical Evaluation in Heart Failure
- Status
- Recruiting
- People taking part
- 450 people, planned
- Started
- 15 Oct 2026
- Expected to end
- Dec 2027
- Type of study
- Observational
- Treatments tested
- Daily Voice Recording
- Record updated
- 27 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 22 or older with Stage C heart failure who had a worsening heart failure event in the last 180 days.
- Age
- 22 years or older
- Sex
- All sexes can join.
- Disease stage
- Heart failure, Stage C, with a decompensated heart failure (DHF) event within the prior 180 days.
Main reasons for not taking part
- Monitored with implantable volume or pressure monitoring devices
- Planned cardiac surgery or major intervention (for example LVAD or transplant)
- Unable or unwilling to follow study procedures
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Age ≥22
- HF diagnosis (Stage C)
- DHF event within prior 180 days
Who cannot take part
- Planned cardiac surgery or major intervention (e.g., LVAD or transplant), or
- Monitoring with implantable volume or pressure monitoring devices, or
- Otherwise inability or unwillingness to comply with study procedures
Where in United States
- Brigham and Women's HospitalBoston, United StatesContact: Ameesh Isath, MBBSTaking people
About the trial
What the trial wants to find out
VOICE-HF is a clinical study designed to evaluate the performance of a novel non-invasive software device (Noah Labs Vox) that uses vocal characteristics to estimate DHF risk and has strong potential for clinical success. This study will compare the performance of Noah Labs Vox with the contemporary performance of commonly used weight-based remote monitoring rules and applications to determine efficacy and safety.
The group in the trial
- Voice-Based Monitoring Group
All participants receive standard heart failure care as per local standard of care, plus daily voice monitoring via a mobile application. Patients record voice samples and answer symptom questions daily. Sites and participants are blinded to the results, which are analyzed retrospectively.
Treatment: Daily Voice Recording
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Voice-based Outcome Identification and Clinical Evaluation in Heart Failure
- Plain-language title
- Using daily voice recordings to estimate risk of worsening in heart failureGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 27 October 2026